Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Griffith

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
European Heart Journal|March 1, 1996
The Sicilian gambit: an opening move that loses the game?C J Garratt, M J Griffith
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|November 22, 1972
The liver as a site for interferon production in response to poly I:poly CW E Magee, M J Griffith
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 28, 2001
Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patientsH J Marshall, M J Griffith
Biochemical and Biophysical Research Communications|November 14, 1984
Evidence for essential lysines in heparin cofactor IIF C Church, M J Griffith
Thrombosis and Haemostasis|February 28, 1986
Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogsG A Marbet, M J Griffith
Heart (British Cardiac Society)|December 10, 1997
Management of asymptomatic aortic stenosis: masterly inactivity but cat-like observationJ C Vaile, M J Griffith
Pacing and Clinical Electrophysiology : PACE|May 1, 1996
Diagnosis of wide complex tachycardiaC J Garratt, M J Griffith
Biochemical and Biophysical Research Communications|April 29, 1983
Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor IIM J Griffith, G A Marbet
Blood|May 1, 1985
The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activationT B McNeely, M J Griffith
Journal of Health Care Marketing|December 6, 1984
Awareness by consumers and the adoption of a new service: an HMO exampleM J Griffith, J A Wells
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
European Heart Journal|March 1, 1996
The Sicilian gambit: an opening move that loses the game?C J Garratt, M J Griffith
Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology|November 22, 1972
The liver as a site for interferon production in response to poly I:poly CW E Magee, M J Griffith
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 28, 2001
Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patientsH J Marshall, M J Griffith
Biochemical and Biophysical Research Communications|November 14, 1984
Evidence for essential lysines in heparin cofactor IIF C Church, M J Griffith
Thrombosis and Haemostasis|February 28, 1986
Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogsG A Marbet, M J Griffith
Heart (British Cardiac Society)|December 10, 1997
Management of asymptomatic aortic stenosis: masterly inactivity but cat-like observationJ C Vaile, M J Griffith
Pacing and Clinical Electrophysiology : PACE|May 1, 1996
Diagnosis of wide complex tachycardiaC J Garratt, M J Griffith
Biochemical and Biophysical Research Communications|April 29, 1983
Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor IIM J Griffith, G A Marbet
Blood|May 1, 1985
The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activationT B McNeely, M J Griffith
Journal of Health Care Marketing|December 6, 1984
Awareness by consumers and the adoption of a new service: an HMO exampleM J Griffith, J A Wells
Pageof 12